文献速递腹部MR

糖耐量异常患者胰腺细胞外容积分数的T1 mapping评估

Pancreatic extracellular volume fraction using T1 mapping in patients with impaired glucose intolerance.
PubMed 文献 · Abdom Radiol (NY) · 2020-01-01

前瞻性纳入45例已知或疑似胰腺疾病患者,行包括T1 mapping的增强MR检查,按HbA1c分为无糖尿病、糖尿病前期和2型糖尿病三组。结果显示HbA1c与胰腺平扫T1值及ECV均正相关(r=0.79和r=0.60,P<0.001),2型糖尿病组两项指标均显著高于其他两组,ECV鉴别2型糖尿病的敏感度、特异度和AUC分别为100%、93.5%和0.990,优于平扫T1值的84.6%、96.8%和0.906。

要点

  • 胰腺ECV与HbA1c正相关(r=0.60,P<0.001),或可反映胰腺纤维化。
  • ECV鉴别2型糖尿病的敏感度100%、特异度93.5%、AUC 0.990。
  • ECV的鉴别效能优于平扫胰腺T1值(AUC 0.906)。

关键影像表现/征象

  • 2型糖尿病组胰腺平扫T1值和ECV均显著高于无糖尿病组和糖尿病前期组(P<0.001)。
  • 无糖尿病组与糖尿病前期组之间胰腺平扫T1值和ECV均无显著差异(P=0.14)。

诊断标准与关键数值

  • ECV鉴别无糖尿病和糖尿病前期与2型糖尿病:敏感度100%、特异度93.5%、AUC 0.990。
  • 平扫胰腺T1值鉴别无糖尿病和糖尿病前期与2型糖尿病:敏感度84.6%、特异度96.8%、AUC 0.906。
  • HbA1c与胰腺平扫T1值正相关(r=0.79,P<0.001),与ECV正相关(r=0.60,P<0.001)。

临床应用与阅片要点

  • 作者认为胰腺ECV可能作为评估导致糖耐量异常的胰腺纤维化的潜在影像生物标志物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate pancreatic T1 mapping and extracellular volume (ECV) fraction's feasibility to assess impaired glucose tolerance (IGT) patients.

METHODS: A total of 45 consecutive patients with known or suspected pancreatic disease underwent contrast-enhanced magnetic resonance (MR) imaging, including T1 mapping, using saturation recovery sequence. Patients were classified into three groups based on the American Diabetes Association criteria: no-diabetes subjects, HbA1c < 5.7%; pre-diabetes, 5.7% ≤ HbA1c < 6.5%; and type 2 diabetes mellitus (T2DM), HbA1c ≥ 6.5%. Pre-contrast pancreatic T1 value and ECV of the pancreas were computed, and then pre-contrast pancreatic T1 value, ECV and HbA1c values were compared. The present prospective study was approved by our institutional review board. Written informed consent was obtained from all patients.

RESULTS: A positive correlation between HbA1c values and both pre-contrast pancreatic T1 value and ECV (r = 0.79, P < 0.001 and r = 0.60, P < 0.001, respectively) were observed. The pre-contrast pancreatic T1 value and ECV were significantly higher in T2DM vs. no-diabetes subjects and pre-diabetes (P < 0.001). No significant difference between two qualitative values (P = 0.14) was found, however, the sensitivity, specificity, and area under the receiver-operating-characteristic curve differentiating no-diabetes subjects and pre-diabetes from T2DM were superior in ECV (100%, 93.5%, and 0.990) vs. pre-contrast pancreatic T1 values (84.6%, 96.8%, and 0.906).

CONCLUSIONS: The ECV of the pancreas could serve as a potential imaging biomarker for the assessment of pancreatic fibrosis leading to IGT.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Noda Y, Goshima S, Tsuji Y, et al. Pancreatic extracellular volume fraction using T1 mapping in patients with impaired glucose intolerance. Abdom Radiol (NY). 2020. PMID: 31894382. doi:10.1007/s00261-019-02384-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。